A lloreactivity is the ability of a T cell to recognize foreign MHC molecules to which the T cell had never been exposed, and occurs in a relatively high frequency of unprimed T cells (1) . The study of alloreactivity led to the identification of the MHC as a whole and to the recognition of class I and class II gene products, and the concept has been an important component of immunology ever since (2, 3) . Alloreactivity is observed in vivo as graft rejection or graft-vs-host disease and in vitro by a MLR. Alloresponses against class I and class II molecules are readily detectable, and both are important clinically. Alloreactivity evolves from the ability of the ␣␤ TCR to recognize a foreign MHC molecule, and self-peptides bound to the MHC molecule are an integral part of this recognition. There were several studies strongly implicating self-peptides in alloreactivity (4 -6) , and direct proof was obtained by Sherman and colleagues (7) for an H-2K b alloresponse. Most studies of alloreactivity focused on class I restricted responses because of the available MHC mutants (K bm series) and the cell lines that possessed defined defects in the class I presentation pathway (8 -10) . Class II alloresponses were also described, and several of them were explored in detail (11) (12) (13) (14) (15) ). The precise role of self-peptides in the alloresponse of an individual T cell has not yet been determined. The 2.102 T cell is specific for Hb 3 /I-E k and has been used extensively in our study of altered peptide ligands and partial T cell activation (16 -18) . We discovered that the 2.102 T cells (hybridomas, clones, and TCR transgenic T cells) are alloreactive to I-E p molecules and characterized this recognition event (19, 20) . Evidence of an important role for self-peptides in this alloresponse is the inability of CHO cells transfected with I-E p molecules to stimulate 2.102 T cells. The class II molecules in CHO cells do not access the endocytic pathway, and, thus, the cells do not express any appreciable levels of self-peptides. Essentially, nothing was known about I-E p molecules, including any self-peptides. Therefore, we generated an allomimic peptide, termed EPM, using an I-E p ␤-galactosidase epitope and a sequential combinatorial peptide technique. EPM presented on I-E p strongly stimulated 2.102 T cells, demonstrating a key role of the peptide in this alloresponse. We then explored the recognition of EPM by 2.102 T cells and found that it was more degenerate than that observed for Hb/I-E k , especially at the P5 TCR contact residue. To examine the contribution of the I-E p residues, we recapitulated the alloreactivity of I-E p by mutation of the well-characterized I-E k molecule. Six of the 20 differences between I-E k and I-E p are located on the ␤-chain ␣ helix, and 14 are on the ␤-strands of the peptide-binding groove. We generated a mutant I-E k molecule, I-Ek ⌬6 , in which the six residues on the ␤-chain ␣ helix were substituted by those present in I-E p , and reconstituted the 2.102 alloreactivity. We showed that these I-E p helical residues were responsible for the broadened peptide recognition. From these studies, we were able to identify and characterize the 2.102 alloresponse against I-E p and demonstrate the critical involvement of peptides.
In this study we explored the role of self-peptides in I-E p alloreactivity. To this end, we used capillary HPLC coupled via electrospray ionization to tandem mass spectrometry (MS/MS) to identify and sequence self-peptides naturally bound and presented by I-E p . This information was used to define the I-E p binding motif and identify potential alloligands. We found that the I-E p binding motif is distinct from that of the other I-E molecules. In addition, we used the I-E p binding motif to search the mouse genome database for self-peptides that possessed allowable TCR contact residues and that might stimulate 2.102. Two potential allopeptides were identified, one of which, G protein-coupled receptor 128 (GPR128), strongly stimulated 2.102 T cells. Analysis of the stimulatory GPR128 peptide revealed that residues beyond the P9 anchor residue are essential to the recognition of GPR128, which contrasts with 2.102 reactivity to Hb (64 -76) or EPM. This finding suggests that either there is a slight shift in how the 2.102 TCR contacts the GPR128/I-E p complex or that the P10 and P11 residues alter the conformation of the GPR128 peptide in the MHC. Through the combined use of MS/MS and bioinformatics to identify self-peptides, a single candidate allopeptide was identified, thus demonstrating a degree of specificity in the alloresponse.
Materials and Methods

Mice
C57BL/6J (B6, H-2 b ) and B6.AK-H2 k /FlaE (hereafter referred to as B6.K) mice were purchased from The Jackson Laboratory, and BALB/c (H-2 d ) mice were obtained from Charles River Laboratories. B6.P (H-2 p ) mice were generated by backcrossing B10.P mice (originally obtained from D. Shreffler's colony) to the C57BL/6J line for six generations and intercrossing to produce the B6.P strain. All mice were bred and housed under specific pathogen-free conditions in the animal facility at the Washington University Medical Center.
Cell lines and mAbs
The 2.102 T cell hybridoma, CH27-E p and CHO-E p cells have been described previously (18 -20) . The 2.102 and CH27-E p cell lines were cultured in RPMI 1640 containing 10% FCS (HyClone), whereas CHO-E p cells were cultured in MEM-␣ containing 5% FCS. Media were supplemented with 2 mM GlutaMAX (Invitrogen Life Technologies), 5 ϫ 10 Ϫ5 M 2-ME, and 50 g/ml gentamicin. To generate a cell line that expresses a high level of I-E p , we fused LPS-activated spleen cells from B6.P mice with the class II negative M12.C3 B cell line. This approach has been successfully used in previous studies with similar cells. The fused cells were sorted once for high expression of I-E p and cloned. Individual clones were tested for the ability to stimulate 2.102 T cells and for expression of high levels of I-E p . The B6P.C3 cell line was selected based on its stable expression of high levels of I-E p and its ability to strongly stimulate the 2.102 T cell. B6P.C3 cells were cultured in DMEM containing 7% FCS, 25 mM HEPES, 0.1 mM nonessential amino acids, and the above-listed supplements. The 14.4.4s mAb, specific for the I-E ␣-chain, was obtained from the American Type Culture Collection. The mAb 2B6.B8, specific for the I-E p ␤-chain, was described previously (19) .
Purification of peptides from I-E p
Peptides were purified from I-E p class II molecules following an established protocol (21, 22) . Briefly, B6P.C3 cells (3-5 ϫ 10 9 ) were lysed in PBS containing the detergents octanoyl-N-methylglucamide (MEGA 8) and nonanoyl-N-methlyglucamide (MEGA 9) (40 mM each) and protease inhibitors. After incubation at 4°C for 1 h, the lysate was cleared by centrifugation at 10,000 ϫ g for 30 min. I-E p class II molecules were purified by using the mAb 2B6.B8 coupled to cyanogen bromide-activated Sepharose beads. Beads were collected on a disposable chromatography column and washed extensively with PBS and MilliQ H 2 O. I-E p -peptide complexes were eluted with 0.1% trifluoroacetic acid, and peptides were separated from the individual MHC chains by centrifugation through a Centriprep YM-10 membrane (Millipore).
Liquid chromatography (LC)-MS
MHC peptide extracts from B6P.C3 and CH27-E p lines were analyzed by on-line reverse phase (RP) LC-MS and MS/MS and/or by off-line strong cation exchange LC followed by on-line RP-LC-MS/MS (two-dimensional LC-MS). When two-dimensional LC was used, off-line strong cation exchange was performed. Samples were resuspended in solvent C (30% CH 3 CN, 0.1% formic acid (FA)). Ten microliters was injected using an Ultra-Plus II LC with flow split to 5 l/min and a polysulfoethyl column (15 cm ϫ 320 m, Microtech Scientific). The gradient was from 0% solvent D (30% CH 3 CN, 0.1% FA, and 1 M ammonium acetate) to 25% solvent D at 35 min, 50% solvent D at 50 min, and 100% solvent D at 65 min. Ten 7-min fractions were collected, dried down, and resuspended in 10 l of solvent A (3% CH 3 CN and 0.1% FA). Five microliters was injected for on-line RP-LC electrospray ionization-MS as described below, and product ion spectra were obtained by using data-dependent MS/MS scanning.
For the on-line reverse phase portion, two LC-MS systems were used. For both systems 5 l of a sample was loaded onto a silica capillary column with a PicoFrit TM tip (New Objective) packed in-house with C 18 RP material (0.075 ϫ 100 mm, 5-m, 300-Å; Delta-Pak, Waters). The gradient was from 0% solvent B (97% CH 3 CN, 3% H 2 O, and 0.1% FA) to 50% solvent B over 70 min.
For the LCQ Deca ion trap system the gradient was pumped using a Waters CapLC, and eluent flow was ϳ5 l/min and split before the column at a ϳ1:25 ratio to maintain a flow rate at the tip of 260 nl/min. Flow was directed into the entrance of the heated capillary of an LCQ Deca quadrupole ion trap mass spectrometer (Thermo-Electron) equipped with a custom-built nanospray source. For MS, the scan range was m/z 600-1400 in the profile mode. For MS/MS, the scan range was from 30% of the m/z of the parent ion to m/z 2000. The isotope clusters of parent ions were dynamically selected and isolated with a 2.5 m/z window. The collision energy was set to 28% of the maximum, which is ϳ5 eV. For detection of peptides, the mass spectrometer selected peptides based on their signal intensity. In such experiments, the first and second most abundant precursor ions were selected for MS/MS analysis.
For the linear ion trap LTQ-Fourier transform system the gradient flow was generated by an Eksigent Technologies nanoLC-1D system at a splitless flow rate of 260 nl/min and directed into an LTQ-Fourier transform (Thermo Electron) using a PicoView PV500 (New Objective) nanospray source. The MS parameters were similar to those of the LCQ Deca system; however, the relative collision energy was 30%, and the eight most abundant ions were selected for MS/MS analysis.
All product-ion spectra were analyzed, and peptide sequences were determined automatically using MASCOT software (Matrix Science). All of the automatically determined sequences were manually verified against the experimental product ion spectra.
Peptide synthesis
Peptides were synthesized using standard Fmoc chemistry on a Rainin Symphony/Multiplex multiple peptide synthesizer (Protein Technologies). Peptides were purified by reverse phase HPLC on a C 18 column (Vydac), and molecular mass and purity were confirmed by MALDI mass spectrometry (Washington University Mass Spectrometry Facility).
T cell hybridoma response
Activation of the 2.102 hybridoma was detected by assaying for the production of IL-2 in the tissue culture supernatant. The 2.102 T cell hybridoma cells (1 ϫ 10 5 ) were cultured for 24 h with CHO-E p APCs (2 ϫ 10 3 ) and a range of peptide concentrations. Supernatants (100 l) were removed and added to the IL-2 dependent CTLL-2 line (5 ϫ 
Limiting dilution analysis (LDA)
B6 and B6.K spleen and lymph node cells were depleted of class II-positive cells using MACS beads and columns (Miltenyi Biotec) in accordance with the manufacturer's protocol. Following depletion, the percentage of CD4 and CD8 single-positive cells was determined by FACS analysis. Various concentrations of B6 or B6.K lymphocytes were cultured with 5 ϫ 10 5 irradiated B6.P spleen cells (2,000 rads) in 96-well U-bottom plates in medium containing 50 U/ml IL-2. After seven days, growth-positive wells were expanded into four wells under the same conditions. After an additional 7 days, the specificity of the cells was determined in a proliferation assay against irradiated B6.P and syngeneic spleen cells in the absence of exogenous IL-2. T cell clones with thymidine incorporation Ͼ250 cpm and Ͼ2-fold above the control values were considered to be Ag-specific. To determine the frequency of alloresponders specific for I-E p , T cell responses were blocked with the anti-I-E p Ab 2B6.B8 (10 g/well). The frequency of alloreactive T cells was determined according to the maximum likelihood method (23) with two previously described modifications to the formula (24) .
Flow cytometric analysis
Samples were stained according to established protocols in PBS containing 0.5% BSA and 0.02% NaN 3 . Cells were incubated at 4°C for 1 h with directly labeled or biotinylated primary Abs, followed by streptavidin-FITC secondary reagent, if needed. Cells were analyzed on a FACScan flow cytometer using CellQuest software (BD Biosciences).
Peptide binding assays
Peptide binding was measured by competitive ELISA essentially as described elsewhere (25, 26) . Purified I-E p MHC class II molecules (1 M) were incubated with 300 nM biotinylated reference peptide (biotin-6-aminohexanoic acid-TTRVNHATPSAAYA) and various concentrations of competitor peptide in 0.1 M citrate/phosphate buffer (pH 5.0) with 0.2% Nonidet P-40 and protease inhibitors. After 48 -72 h at 37°C, peptide/I-E p complexes were captured on Immulon II 96-well microtiter plates coated with the 14.4.4s Ab. Biotinylated-peptide/I-E p complexes were detected by streptavidin-HRP dependent color change. Peptide binding is expressed as IC 50 , the amount of peptide needed to inhibit binding of the reference peptide by 50%.
Results
Frequency of allo-I-E p responses
The H-2 p MHC haplotype, expressed in P/J, C3H.NB, B10.P, and B6.P mice, was studied immunologically in a limited manner previously, mostly involving the I-A p molecule in autoimmune diseases (27) (28) (29) (30) . To put our finding of the 2.102 I-E p alloreactivity into a broader immunological context, we wanted to determine the alloprecursor frequency specific for naive T cells against I-E p . We performed LDA using two different responder populations to examine the number of T cell precursors capable of recognizing I-E p . First, B6.K (H-2 k ) T cells were tested for the ability to respond to cells from B6.P mice. The B6.K responder strain was chosen because it is of the same genetic background as B6.P, thus eliminating any minor H differences. In addition, B6 (H-2 b ) T cells were also used as responders. Because B6 mice do not express I-E molecules, the T cells in these animals are neither positively nor negatively selected for reactivity to I-E, potentially affecting the level of alloreactivity.
LDA established an overall alloreactive precursor frequency of one in 1547 for B6.K T cells and one in 1645 for B6 T cells (Table  I) . These values are within the range that was reported for other alloreactivities against only an H-2 difference. By comparison, when both major and minor H differences were present (B6 vs BALB/c) we observed a precursor frequency of one in 950 (data not shown). The portion of the H-2 p response that was specific for I-E p was determined by using an I-E p -specific blocking Ab. Approximately one in 4500 B6.K T cells and one in 9800 B6 T cells are capable of recognizing I-E p . Interestingly, mice expressing an I-E molecule have a modest increase in the frequency of I-E-specific alloreactive T cells. These studies establish that alloreactivity to I-E p represents a conventional and strong primary immune response.
Isolation and identification of peptides from I-E p
To define the 2.102 allorecognition of I-E p at a molecular level, we needed to characterize the self-peptides bound to I-E p . The I-E p peptide-binding motif has not been established, and nothing is known about the self-peptides presented by I-E p . To facilitate the isolation of the naturally processed and presented peptides selected by I-E p , we generated a cell line (B6P.C3) that expresses a high level of I-E p on its cell surface (Fig. 1A) . Importantly, this line strongly stimulates 2.102 T cells (Fig. 1B) , confirming the presence of the alloepitope(s) on the B6P.C3 cell line.
We identified naturally processed and presented peptides selected by I-E p and defined the I-E p peptide binding motif by using an approach involving MS that we (J. J. Walters and A. Suri) have successfully used to characterize the peptides bound to I-A d and I-A g7 molecules (21, 22) . Peptides were eluted from purified I-E p molecules, separated by capillary HPLC, introduced into the mass spectrometer via electrospray ionization, and sequenced using MS/ MS. We isolated and identified a total of 295 peptides (Table II presents some of the data; other data not shown). Similar to peptides eluted from other class II molecules, the peptides isolated from I-E p ranged from 8 to 34 amino acids in length, with most falling between 13 to 20 residues (21, 22, (31) (32) (33) (34) (35) (36) (37) (38) . The 295 peptides were found in 120 different families. A peptide family consists of a series of peptides that contain the same nine-amino acid core sequence and vary by the lengths of their N-and C-terminal flanking residues. The peptides were derived primarily from proteins of the plasma membrane, vesicular, and cytosolic compartments. To verify the ability of these peptides to bind I-E p , 35 peptides were synthesized, purified, and tested for their binding to I-E p . Of these, 13 peptides bound strongly with an IC 50 of Յ10 M, whereas six others bound more weakly, with an IC 50 between 11 and 100 M. The remaining peptides had an IC 50 of Ͼ100 M (i.e., showed no detectable binding in the competitive assay) and were excluded from further analysis. It is possible that these peptides are contaminants, as was observed in previous studies (21, 22) , or that they require the presence of chaperones (e.g., H2-DM) for proper loading onto I-E p . This demonstrates the importance of verifying a peptide's ability to bind by testing in a direct binding assay. Thus, we have successfully identified endogenous peptides bound to I-E p , and these peptides are a "data base" that can be used to characterize the I-E p binding motif.
Identification of the I-E p binding motif
To establish the I-E p peptide binding motif we initially made use of the well-characterized I-E k molecule and its binding motif (32, 34, 37, 39) , given the overall similarity between these two MHC a The alloreactive T cell precursor frequency was determined by limiting dilution analysis. Alloreactive T cells specific for I-E P were identified by blocking alloreactivity with an I-E P -specific monoclonal antibody (10 g/well).
alleles (40) . Sequence comparison of the I-E p and I-E k ␤-chains suggests that the polymorphic differences between the two class II molecules will have the largest impact on the P9 pocket and perhaps a smaller impact on the P6 and P4 pockets (41, 42) . Given that I-E p and I-E k have identical I-E␣-chains, the P1 pocket is completely conserved between the two molecules. Based on this conserved P1, we determined a preliminary I-E p binding register that places Ile, Leu, or Val as the P1 anchor. Importantly, almost every peptide we identified had at least one of these residues near its amino terminus that could serve as the P1 anchor. To ensure the accuracy of our I-E p binding motif analysis and eliminate the impact of nonbinding peptides, we limited our analysis to only those peptides that were determined to bind I-E p . As a result, the binding motif may under-represent the occurrence of certain residues at individual anchor positions. Alignment of the peptides capable of binding I-E p (IC 50 , Ͻ100 M) according to a conserved P1 also suggested that the P9 anchor of I-E p would be distinct from the P9 anchor of the other I-E molecules.
The dominant binding register for the peptides isolated from I-E p was determined by individually replacing each potential anchor residue with Lys and measuring its effect on binding (Table  III) . Substitution of Lys for the wild-type P9 residue decreased peptide binding between 8-and 30-fold compared with the wildtype peptides. Interestingly, the P9 pocket of I-E p predominantly prefers Gln, but Ala, Thr, and Pro are also commonly found (Fig.  2) . This is unlike I-E k and the other I-E molecules, which prefer Lys or Arg at P9. In fact, our Lys scan demonstrated that I-E p disfavors Lys at P9.
The P6 pocket of I-E p accommodates mainly nonpolar aliphatic amino acids (Val, Pro, Ala, Ile, and Leu) but also accepts small polar residues (Ser and Thr) and may occasionally accommodate a charged residue (Fig. 2) . By contrast, the P4 pocket prefers small polar residues (Thr and Ser) and small aliphatic residues (mainly Ala). The P4 pocket appears to contribute significantly to peptide binding, because Lys substitution at this position abolished binding for all tested peptides. The Lys mapping approach validated the initial assumption that P1 is conserved between I-E p and I-E k . A similar analysis of I-E k -bound self-peptides revealed that no peptides were found to bind both I-E k and I-E p (our manuscript in preparation). These results demonstrate that the allocomplex recognized by 2.102 will differ from the Hb(64 -76)/I-E k complex both by the ␣ helical differences between I-E p and I-E k and by the unique spectrum of peptides displayed by I-E p . In fact, any I-E p specific alloresponse has the potential to be directed against both of these distinguishing features of I-E p .
Testing the role of self-peptides in alloreactivity
Having identified the set of self-peptides naturally bound to I-E p , we wanted to ascertain the contribution that these peptides made in the 2.102 alloresponse. Our previous data implied that self-peptides make a significant contribution to the alloreactivity, but we never investigated the frequency of peptides that can make this contribution. To this end, we synthesized and tested a set of 19 different I-E p peptides for their ability to stimulate 2.102 T cells by using CHO-E p as APC. None of the peptides stimulated the 2.102 T cells, even at concentrations up to 100 M (data not shown). Therefore, the peptide(s) involved in the 2.102 I-E p alloresponse make a significant contribution to the recognition surface. In one proposed model for alloreactivity, the role of the self-peptide is merely to stabilize MHC molecules and not to contact the TCR directly (1, 43, 44) . Our data strongly argue against that model; 19 tested self-peptides all stably bind to I-E p molecules, but none stimulate 2.102 T cells.
Identification of a 2.102 reactive candidate allopeptide
To identify potential 2.102 alloreactive peptide(s), we considered two different approaches. Purifying MHC-bound peptides, testing the peptides for their T cell stimulatory activity, and then identifying the peptides by MS has been a successful approach for class I peptides (45) (46) (47) (48) (49) . However, for class II-restricted peptides this approach is much more difficult because the T cell assays are less sensitive, the availability of APCs lacking self-peptides is limited, and the length of the bound peptides is heterogeneous. In fact, to date no unknown peptide bound to a class II molecule possessing a specific T cell reactivity has been identified. With the recently available complete mouse genome and our I-E p peptide-binding motif we chose to pursue a bioinformatics approach to identify candidate allopeptides. We searched the National Center for Biotechnology Information (NCBI) protein database for potential 2.102 reactive allopeptides. The search sequence was based on the core motif of EPM with specific substitutions at P1 (Val, Ile, or Leu), P5 (Trp or Asn), and P9 (Ser or Gln) (Fig. 3A) . Each possible combination of substitutions at P1, P5, and P9 was used to search the NCBI murine protein database. Each search returned nearly 100 sequences, with many sequences appearing in more than one search. The resulting sequences were evaluated for their likelihood to bind to I-E p based on strong P1 and P9 anchor residues and for the overall similarity of their TCR contact residues to EPM. However, the only required conserved TCR contact was at P5 (Trp or Asn). We synthesized two peptides that satisfied these criteria and tested them for the ability to stimulate the 2.102 T cells when presented by CHO-E p cells. Significantly, a peptide derived from the GPR128 protein strongly stimulated the 2.102 hybrid (Fig. 3B) . The GPR128 protein is broadly expressed and it is highly expressed in the spleen. However, the level of GPR128 expression in APCs is not known. Therefore, GPR128 represents a natural allopeptide candidate but may not be the actual allopeptide recognized by 2.102. The other peptide, derived from RNA PAF53 (PAF53), did not stimulate 2.102 T cells (Fig. 3B) .
Analysis of the GPR128 sequence revealed two key features: it is very hydrophobic in nature and is highly homologous to EPM, the allomimic peptide we had generated previously (20) . Initial attempts to purify the synthesized GPR128 peptide were unsuccessful because of this peptide's extreme hydrophobicity. To verify that the GRP128 peptide could stimulate the 2.102 hybrid, we re-synthesized the GPR128 peptide as the original 15-mer peptide and as 13-mer and 9-mer peptides (Fig. 4A) . In addition, we also synthesized two GPR128 variants that contained the sequence GKK at the N-terminal region of the peptide, which is known to a This is a partial list showing 56 of 120 identified peptide families (the complete list is available upon request). Peptide sequences were determined by MS/MS analysis. All sequences are of murine origin unless indicated otherwise. Binding analysis was performed at pH 5.0 and is expressed as IC 50 values. NB, Non-binder; TBP, TATA-binding protein.
increase solubility (P. M. Allen, unpublished observation). The substitution of GKK for the wild-type residues at P-4 through P-2 is not expected to influence TCR recognition but should significantly improve solubility.
The unpurified GPR128 15-mer peptide stimulated the 2.102 T cell hybrid when presented in the context of I-E p (Fig. 4B) . Importantly, MALDI of the unpurified peptide demonstrated that the expected full length GPR128 peptide was the major product of our synthesis ([M ϩ H ϩ Na] ϩ ion of m/z 1755.1; data not shown). However, we were unable to identify reverse-phase HPLC conditions that permitted purification of the wild-type GPR128 peptide. By contrast, both GPR128 GKK peptides were soluble and easily purified. Significantly, the purified GPR128 GKK peptide strongly stimulated 2.102 (Fig. 4B) . These results establish GPR128 as a candidate allopeptide recognized by the 2.102 TCR and validate this bioinformatics approach.
Specificity in the recognition of alloreactive peptides
We also synthesized and tested the wild-type and GKK analog 13-mer peptides that lack the C-terminal Ala and Thr at positions P10 and P11. Surprisingly, the 13-mer GKK analog only weakly stimulated the 2.102 hybrid (Fig. 4C) . Consistent with the results of the GKK 13-mer analog, the unpurified wild-type GPR128 13-mer peptide failed to stimulate the 2.102 T cell hybrid (Fig. 4C) . These results show that the 2.102 TCR is influenced by the P10 and P11 residues of GPR128, which are not critical for 2.102 recognition of Hb/I-E k . For other T cells, C-terminal extensions were shown to be critical for their conventional reactivity (50) .
The failure of PAF53 to stimulate 2.102 cannot be explained by an inability to bind I-E p , because it bound I-E p well (Fig. 3a) . Nonstimulatory PAF53 differs from GPR128 at P2 and P7 (Fig.  3A) . Although PAF53 also differs at P5 (Asn) compared with GPR128 (Trp), this difference is unlikely to influence negatively 2.102 recognition. We previously determined that at P5 Asn is equivalent to Trp in its ability to stimulate 2.102 (N. J. Felix, unpublished observation). Thus, despite the overall similarity of the two candidate allopeptides, 2.102 has a degree of specificity for the allopeptide it recognizes.
Having identified GRP128 as a potential source of a 2.102 allopeptide, we reexamined our MS data of I-E p eluted peptides to find any evidence that this epitope is naturally processed and presented. We were unable to identify any species with a mass that would match the GPR128 allopeptide in the MS analysis. This, however, is not unexpected given the hydrophobic nature of this peptide and our difficulty in purifying it using conventional reverse-phase HPLC. It is likely that the natural peptide either never dissolved or was not eluted from the column. To determine whether reactivity to GPR128 is a feature of a broad alloresponse, we tested the ability of naive B6.K T cells to proliferate in response to the GPR128 GKK 15-mer peptide presented by CHO-E p cells. Although we were unable to detect a proliferative response to GPR128 by this assay (data not shown), this failure does not indicate that a response to GPR128 cannot occur. Instead, it may reflect a low precursor frequency of alloreactive T cells capable of recognizing the GPR128/I-E p complex. Although we cannot definitively identify GPR128 as the allopeptide recognized by the 2.102 TCR, GPR128 represents a potential source of a 2.102 reactive allopeptide, and the specificity of its recognition reveals the critical role peptides play in alloreactivity.
Discussion
Previous work has established that self-peptides play an important role in direct recognition of allogeneic MHC (1, 7, 46, 47, 49, (51) (52) (53) (54) (55) (56) (57) (58) (59) . In only a few cases has peptide-independent allorecognition been demonstrated for class I, and these cases are the exception (60 -62) . However, the extent of specificity for the bound peptide has not been firmly established, especially for class II responses. In this study we report the identification of GPR128, a candidate allopeptide recognized by the 2.102 TCR, and demonstrate the specificity of the recognition by 2.102 of allogeneic I-E p . Our results suggest that 2.102 is only capable of recognizing a limited number of self-peptide/I-E p complexes and support the theory that allorecognition is a relatively peptide-specific event.
The high frequency of alloreactive T cell precursors has been attributed to the high density of self-peptide/allo-MHC complexes Transferrin Receptor (193-207)
The dominant binding register of peptides isolated from I-E P was determined by indi-vidual substitution of potential anchor residues with Lys. Binding assays were performed at pH 5.0. Dash indicates the residue listed above in the wild-type (WT) line. NB, Non-binder.
residues for GPR128 and the nonstimulatory RNA PAF53, it is not immediately apparent why GPR128 is active. In fact, 2.102 responds very differently to three relatively similar peptides (GPR128, PAF53, and EPM). This observation is illustrated by the discovery that the GPR128 13-mer peptide fails to stimulate 2.102 cells. The 2.102 TCR is not dependent upon the P10 and P11 residues of Hb or EPM, but these residues are clearly involved in the allorecognition of the GPR128/I-E p complex. This finding implies that for 2.102 allorecognition of GPR128/I-E p there might be a slight shift in the orientation of the TCR bound to the peptide-MHC. Alternatively, these residues may alter the conformation of the GPR128 peptide bound to I-E p . Therefore, despite the modest similarity of the GPR128 and PAF53 core peptides, there are also residues laying outside the peptide-binding groove that play a critical role in allorecognition of GPR128. Although this feature is not unique to allorecognition, it provides another mechanism by which peptide recognition can be altered in an alloresponse (50) .
It is clear from these studies that 2.102 has a degree of specificity for the bound peptide. However, the extent of 2.102 peptide specificity is still unknown for alloresponses as well as for conventional responses (69, 70) . The contribution of the I-E p ␣ helical residues to alloreactivity was explored previously (20) . In these studies, mutating the I-E k ␣ helical residues to those of I-E p increased 2.102 degeneracy for Hb (64 -76) at P5. In addition, these mutations altered fine specificity but did not increase degeneracy at P3. Although ␣ helical polymorphisms allow broadened recognition of Hb (64 -76) at the P5 TCR contact residue, the degree of degeneracy promoted by ␣ helical interactions has not been extrapolated to the entire peptide by a similar analysis with simultaneous substitutions at multiple TCR contact residues. Clearly, MHC polymorphisms can alter the fine specificity of alloreactive T cells for the bound peptide, and these effects can either increase or decrease specificity at individual TCR contact residues. However, our analysis of two candidate allopeptides demonstrates that the ␣ helical polymorphisms present on I-E p do not eliminate the role of the bound peptide and that increased degeneracy at a single TCR contact does not, in this case, result in excessive peptide degeneracy. Although a combined tandem MS and bioinformatics approach identified a single self-peptide capable of eliciting 2.102 allorecognition, it is premature to suggest that GPR128 represents the only peptide/I-E p complex recognized by 2.102. Given the presence of polymorphic differences between I-E p and I-E k and the presence of numerous peptides in the murine proteome with similarity to the EPM core motif, as well as the discovery that peptide residues outside the binding grove can contribute to 2.102 allorecognition, it seems likely 2.102 may recognize additional as yet unidentified self-peptides. However, the specificity demonstrated by 2.102 in these studies suggests that any additional selfpeptide/I-E p complexes it recognizes will be limited in number. It has been suggested that a high degree of degeneracy for peptide exists among some alloreactive T cells (1, 43, 59) . Whether there exist multiple types of alloreactive T cells that vary in the extent of their peptide specificity remains controversial. Our results suggest that the 2.102 TCR is relatively peptide-specific, not excessively peptide-degenerate. Additional experiments to define the fine specificity of 2.102 for GPR128 and to exhaustively identify any potential additional allopeptides recognized by 2.102 will help determine the degree to which the polymorphic ␣ helical regions of I-E p substitute for extensive contacts with the bound peptide. Improvements in sensitivity, speed, and specificity will undoubtedly make the use of MS/MS more effective in identifying unknown peptides with specific reactivities from class II molecules. This will be necessary to determine whether self-peptides with substantially divergent sequences can stimulate 2.102 T cells. In addition, our results demonstrate the effectiveness of bioinformatics-based searches when the binding motif and acceptable T cell contact residues are known.
